Warning letter
NatureAll-STF Holding, LLC: warning letter of Jan 31, 2014
FDA warning letter 407555 · Denver District Office
Key facts
| Reference number | 407555 |
|---|---|
| Company | NatureAll-STF Holding, LLC |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Jan 31, 2014 |
| Posted date | Feb 11, 2014 |
| Issuing office | Denver District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101, 101.3, 111, 111.103, 111.210, 111.605, 111.25(a), 111.27(b), 111.35(b)(1)(i), 111.35(b)(3), 111.75(a)(2)(ii), 111.205(a) and 15 more |
| Inspection city | South Salt Lake |
| Inspection ZIP | 84115 |
| Inspection start date | May 30, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: